NYSEARCA:RWCD Direxion MSCI Cyclicals Over Defensives ETF (RWCD) Price, Holdings, & News $77.10 0.00 (0.00%) As of 09/29/2020 Add Compare Share Share Stock Analysis Stock Analysis About Direxion MSCI Cyclicals Over Defensives ETF (NYSEARCA:RWCD) Get RWCD alerts:Sign Up Key Stats Today's Range$77.10▼$77.1050-Day Range$77.10▼$77.1052-Week Range$45.30▼$85.69VolumeN/AAverage Volume1,466 shsMarket Capitalization$13.49 millionAssets Under Management$13.49 millionDividend Yield1.04%Net Expense Ratio0.45%Aggregate RatingN/A ETF Overview Read More Direxion MSCI Cyclicals Over Defensives ETF ExpensesTypeRWCDNYSEARCA ETFsAll ETFsManagement Fee0.40%0.50%0.53%Other Expenses0.20%0.60%0.54%Total Expense0.60%0.75%0.73%Fee Waiver-0.15%-0.78%-0.68%Net Expense0.45%0.57%0.60% Receive RWCD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion MSCI Cyclicals Over Defensives ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RWCD ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com RWCD ETF - Frequently Asked Questions How have RWCD shares performed this year? Direxion MSCI Cyclicals Over Defensives ETF's stock was trading at $77.0990 at the beginning of 2026. Since then, RWCD shares have increased by 0.0% and is now trading at $77.0990. How do I buy shares of Direxion MSCI Cyclicals Over Defensives ETF? Shares of RWCD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details Issuer Fund NameDirexion MSCI Cyclicals Over Defensives ETF Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:RWCD Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings0 Fund Statistics Assets Under Management$13.49 million Average Daily Volume$2.26 thousand Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares175,000BetaN/A 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report RWCD Currency Exposure This page (NYSEARCA:RWCD) was last updated on 9/16/2026 by MarketBeat.com Staff. From Our Partners“This is the Perfect Tech Stock”Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...Brownstone Research | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredNNVC on Alert: FDA Validation and Outperform Rating!NanoViricides (NYSE: NNVC) just landed FDA Rare Pediatric Disease Designation for NV-387 in Measles, adding to...Equiscreen | SponsoredYou’ve never seen anything like this beforeFor centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type ...Porter & Company | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredWhat Is A Roth Conversion, And How Do I Set One Up?A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...SmartAsset | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion MSCI Cyclicals Over Defensives ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion MSCI Cyclicals Over Defensives ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.